Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01290861 · ClinicalTrials.gov registry record

Cognitive Assessment Battery (CAB) Beta Study

A clinical trial, sponsored by CHDI Foundation.

Completed
Registry status
255
Enrollment target

NCT01290861 is a clinical trial that has completed, run by CHDI Foundation. The registered enrollment target is 255 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01290861 has completed, sponsored by CHDI Foundation.

COMPLETED
Registry status
255 participants
Enrollment target

Study Summary

The overall objective of this study is to identify a 60 minute cognitive battery, for subsequent use in clinical trials, that detects cognitive deficits in early HD and late pre-manifest HD compared to controls, and that has a potential to show drug induced improvements.

Trial Details

FieldValue
Enrollment Target 255 participants
Start Date 2011-02

Sponsor

CHDI Foundation

5 total trials

What the Registry Record Tells You About NCT01290861

The ClinicalTrials.gov registry entry for NCT01290861 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CHDI Foundation, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01290861 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01290861 about?

NCT01290861 is a clinical study titled "Cognitive Assessment Battery (CAB) Beta Study". The overall objective of this study is to identify a 60 minute cognitive battery, for subsequent use in clinical trials, that detects cognitive deficits in early HD and late pre-manifest HD compared to controls, and that has a potential to show drug induced improvements.

What is the current status of trial NCT01290861?

This trial is currently completed. The enrollment target is 255 participants. The study started on 2011-02.

Who is sponsoring clinical trial NCT01290861?

This trial is sponsored by CHDI Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.